Encouraging outcomes from a clinical study on the LSD-analog substance MM120, or lysergide d-tartrate, have led the Food and Drug Administration (FDA) to designate it as a “breakthrough therapy” for ...

A clinical trial’s encouraging results won US Food and Drug Administration breakthrough therapy status for an LSD formulation to treat generalized anxiety disorder, Mind Medicine Inc. announced ...

A single dose of the psychedelic drug LSD may ease generalized anxiety disorder for months, a clinical trial has found. The trial results, published Thursday (Sept. 4) in JAMA, include data from 194 ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

Researchers are now testing whether psilocybin can treat severe depression without producing the hallucinogenic trip that has ...

MindMed Inc. said Tuesday it’s on track to launch Phase 3 clinical trials with up to 440 people starting later this year for its treatment of generalized anxiety disorder (GAD) through use of ...

MindMed's LSD tartrate receives breakthrough therapy designation from the FDA for the treatment of generalized anxiety disorder. GAD affects a significant portion of the US population, with high costs ...

Gov. Gavin Newsom signed a bill that will provide $90 million for reproductive health care, offering a lifeline to Planned Parenthood after federal cuts threatened the provider.

“While prior research has documented the benefits of combining LSD with psychotherapy to alleviate anxiety associated with life-threatening conditions, this groundbreaking study is the first to show ...